S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
NYSE:USPH

U.S. Physical Therapy - USPH Earnings Date, Estimates & Call Transcripts

$76.02
-0.15 (-0.20%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$75.82
$77.06
50-Day Range
$74.54
$130.18
52-Week Range
$73.30
$131.50
Volume
144,672 shs
Average Volume
87,938 shs
Market Capitalization
$988.26 million
P/E Ratio
25.95
Dividend Yield
2.15%
Price Target
$121.50

Earnings Summary

Upcoming
Earnings Date
Nov. 3Estimated
Actual EPS
(Aug. 4)
$0.90 Missed By -$0.03
Consensus EPS
(Aug. 4)
$0.93
Last Year's Q3 EPS
(8/5/2021)
$0.96
Skip Charts & View Estimated and Actual Earnings Data

USPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

USPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

U.S. Physical Therapy Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20223$0.63$0.80$0.73 
Q2 20223$0.93$1.06$1.01 
Q3 20223$0.76$0.91$0.86 
Q4 20223$0.62$0.92$0.74 
FY 202212$2.94$3.69$3.33 
Q1 20231$0.82$0.82$0.82 
Q2 20232$0.95$1.00$0.98 
Q3 20232$0.93$0.95$0.94 
Q4 20231$0.96$0.96$0.96 
FY 20236$3.66$3.73 $3.70

USPH Earnings Date and Information

U.S. Physical Therapy last released its earnings data on August 4th, 2022. The reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.93 by $0.03. The business earned $140.70 million during the quarter, compared to analyst estimates of $143.01 million. Its revenue was up 10.9% on a year-over-year basis. U.S. Physical Therapy has generated $2.93 earnings per share over the last year ($2.93 diluted earnings per share) and currently has a price-to-earnings ratio of 25.9. Earnings for U.S. Physical Therapy are expected to grow by 11.11% in the coming year, from $2.70 to $3.00 per share. U.S. Physical Therapy has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off prior year's report dates.

U.S. Physical Therapy Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/3/2022
(Estimated)
        
8/4/2022Q2$0.93$0.90($0.03)$143.01 million$140.70 million    
5/5/2022Q1 2022$0.63$0.65+$0.02$0.63$128.57 million$131.70 million    
2/24/2022Q4 2021$0.69$0.73+$0.04$0.73$128.62 million$129.83 million    
11/4/20219/30/2021$0.78$0.85+$0.07$1.04$124.67 million$125.90 million    
8/5/20216/30/2021$0.74$0.96+$0.22$1.10$125.10 million$126.93 million  
5/6/20213/31/2021$0.47$0.64+$0.17$1.07$110.36 million$112.37 million  
2/25/202112/31/2020$0.83$0.85+$0.02$1.48$118.08 million$117.47 million  
11/5/20209/30/2020$0.51$0.86+$0.35$1.11$103.43 million$108.93 million  
8/6/20206/30/2020($0.18)$0.85+$1.03$0.71$87.24 million$83.86 million  
5/21/20203/31/2020$0.37$0.30($0.07)$0.40$101.89 million$112.70 million  
2/27/202012/31/2019$0.68$0.64($0.04)$0.73$121.45 million$122.11 million  
11/7/2019Q3 2019$0.71$0.71$0.76$121.28 million$117.30 million  
8/8/2019Q2 2019$0.81$0.81$0.77$124.86 million$126.40 million  
5/2/20193/31/2019$0.62$0.66+$0.04$0.93$114.12 million$116.23 million  
3/7/201912/31/2018$0.63$0.71+$0.08$0.99$116.70 million$117.30 million
11/1/20189/30/2018$0.58$0.64+$0.06$1.15$112.79 million$113.10 million  
8/2/2018Q2 2018$0.68$0.73+$0.05$0.98$111.77 million$115.10 million
5/3/2018Q1 2018$0.56$0.56$0.85$107.18 million$108.34 million
3/8/2018Q4 2017$0.49$0.49$0.41$104.12 million$109.20 million
11/2/2017Q3 2017$0.5180$0.48($0.0380)$0.55$102.69 million$103.03 million
8/3/2017Q2 2017$0.6030$0.59($0.0130)$0.79$102.93 million$104.25 million  
6/29/2017Q1 2017$0.49$0.51+$0.02$0.64$97.60 million$97.57 million
6/7/2017Q4 2016$0.49+$0.49$0.50$90.86 million
11/3/2016Q3 2016$0.49$0.46($0.03)$0.46$33.94 million$88.30 million
8/4/2016Q2 2016$0.54$0.57+$0.03$0.57$90.01 million$90.40 million
5/5/2016Q1 2016$0.39$0.43+$0.04$0.43$83.35 million$86.90 million
3/3/2016Q4 2015$0.47$0.48+$0.01$0.48$85.47 million$86.72 million
11/5/2015Q3 2015$0.48$0.47($0.01)$0.47$84.07 million$84.00 million
8/6/2015Q2 2015$0.59$0.51($0.08)$0.51$84.24 million$83.30 million
5/7/2015Q1 2015$0.34$0.34$0.34$74.74 million$77.24 million
3/5/2015Q4 2014$0.39$0.41+$0.02$0.41$75.29 million$79.39 million
11/6/2014Q3 2014$0.42$0.43+$0.01$0.43$75.50 million$77.70 million
8/7/2014Q2 2014$0.45$0.53+$0.08$0.53$74.25 million$66.90 million
5/8/2014Q1 2014$0.29$0.27($0.02)$0.19$67.70 million$62.80 million
3/6/2014Q4 2013$0.35$0.37+$0.02$0.42$65.33 million$62.38 million
11/7/2013Q3 2013$0.38$0.38$0.74$66.32 million$65.83 million  
8/8/2013Q2 2013$0.42$0.41($0.01)$0.41$66.49 million$67.22 million  
5/9/2013Q1 2013$0.32$0.31($0.01)$0.31$62.26 million$63.10 million  
3/7/2013Q4 2012$0.33$0.34+$0.01$61.99 million$62.70 million  
11/8/2012Q312$0.38$0.38$63.77 million$62.80 million
8/9/2012$0.44$0.41($0.03)
5/3/2012$0.34$0.38+$0.04
3/8/2012$0.28$0.29+$0.01
11/3/2011$0.35$0.34($0.01)  
8/4/2011$0.41$0.41  
5/5/2011$0.27$0.31+$0.04
3/3/2011$0.25$0.28+$0.03  
11/4/2010Q3 2010$0.31$0.33+$0.02$0.33
8/5/2010Q2 2010$0.36$0.38+$0.02$0.38
5/6/2010Q1 2010$0.23$0.25+$0.02$0.23
3/4/2010Q4 2009$0.20$0.19($0.01)$0.19
11/5/2009Q3 2009$0.23$0.26+$0.03$0.26
8/6/2009Q2 2009$0.24$0.31+$0.07$0.31
5/7/2009Q1 2009$0.20$0.23+$0.03$0.23
3/5/2009Q4 2008$0.21$0.19($0.02)$0.19
11/6/2008Q3 2008$0.22$0.21($0.01)$0.21
8/7/2008Q2 2008$0.23$0.24+$0.01$0.24
5/8/2008Q1 2008$0.20$0.20$0.20
3/6/2008Q4 2007$0.19$0.21+$0.02$0.21












U.S. Physical Therapy Earnings - Frequently Asked Questions

When is U.S. Physical Therapy's earnings date?

U.S. Physical Therapy has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off last year's report dates. Learn more on USPH's earnings history.

Did U.S. Physical Therapy beat their earnings estimates last quarter?

In the previous quarter, U.S. Physical Therapy (NYSE:USPH) missed the analysts' consensus estimate of $0.93 by $0.03 with a reported earnings per share (EPS) of $0.90. Learn more on analysts' earnings estimate vs. USPH's actual earnings.

How can I listen to U.S. Physical Therapy's earnings conference call?

The conference call for U.S. Physical Therapy's latest earnings report can be listened to online. Listen to Conference Call

How can I read U.S. Physical Therapy's conference call transcript?

The conference call transcript for U.S. Physical Therapy's latest earnings report can be read online. Read Transcript

How much revenue does U.S. Physical Therapy generate each year?

U.S. Physical Therapy (NYSE:USPH) has a recorded annual revenue of $495.02 million.

How much profit does U.S. Physical Therapy generate each year?

U.S. Physical Therapy (NYSE:USPH) has a recorded net income of $40.83 million. USPH has generated $2.93 earnings per share over the last four quarters.

What is U.S. Physical Therapy's price-to-earnings ratio?

U.S. Physical Therapy (NYSE:USPH) has a trailing price-to-earnings ratio of 25.95 and a forward price-to-earnings ratio of 28.16.

What is U.S. Physical Therapy's EPS forecast for next year?

U.S. Physical Therapy's earnings are expected to grow from $2.70 per share to $3.00 per share in the next year, which is a 11.11% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:USPH) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.